N. Ş. Ersöz And A. ADAN, "Differential in vitro anti-leukemic activity of resveratrol combined with serine palmitoyltransferase inhibitor myriocin in FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD) carrying AML cells," Cytotechnology , vol.74, no.2, pp.271-281, 2022
Ersöz, N. Ş. And ADAN, A. 2022. Differential in vitro anti-leukemic activity of resveratrol combined with serine palmitoyltransferase inhibitor myriocin in FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD) carrying AML cells. Cytotechnology , vol.74, no.2 , 271-281.
Ersöz, N. Ş., & ADAN, A., (2022). Differential in vitro anti-leukemic activity of resveratrol combined with serine palmitoyltransferase inhibitor myriocin in FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD) carrying AML cells. Cytotechnology , vol.74, no.2, 271-281.
Ersöz, Nur, And AYSUN ADAN. "Differential in vitro anti-leukemic activity of resveratrol combined with serine palmitoyltransferase inhibitor myriocin in FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD) carrying AML cells," Cytotechnology , vol.74, no.2, 271-281, 2022
Ersöz, Nur Ş. And ADAN, AYSUN. "Differential in vitro anti-leukemic activity of resveratrol combined with serine palmitoyltransferase inhibitor myriocin in FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD) carrying AML cells." Cytotechnology , vol.74, no.2, pp.271-281, 2022
Ersöz, N. Ş. And ADAN, A. (2022) . "Differential in vitro anti-leukemic activity of resveratrol combined with serine palmitoyltransferase inhibitor myriocin in FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD) carrying AML cells." Cytotechnology , vol.74, no.2, pp.271-281.
@article{article, author={Nur Şebnem Ersöz And author={AYSUN ADAN}, title={Differential in vitro anti-leukemic activity of resveratrol combined with serine palmitoyltransferase inhibitor myriocin in FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD) carrying AML cells}, journal={Cytotechnology}, year=2022, pages={271-281} }